Frequently Asked Questions

Get to know Plutus Investment Group, our investment approach and how to connect with our team.

What is Plutus Investment Group LLP?

Plutus Investment Group LLP is a London-based single-family office and venture capital investor focused on early-stage businesses. The firm combines investment capital with strategic guidance, business development support and access to its professional network.

Its investment approach centres on working selectively with companies over the long term. Plutus focuses on five sectors: life sciences, biotechnology, financial technology, technology and defence.

When was Plutus Investment Group founded, and by whom?

Plutus Investment Group was founded in 2021 by Mohammed Jamal, who serves as Founder, Chief Executive Officer and Chairman.

Mohammed Jamal's biography describes a background in structured credit, private equity and venture capital. It lists previous roles at Morgan Stanley and Resource America, followed by the founding of Molton Street Capital and the co-founding of Forepont Capital Group. Further details are available on the company's About Us page.

Where is Plutus Investment Group based and registered?

Plutus Investment Group maintains a London contact address at 83 Baker Street, London, W1U 6AG, United Kingdom.

The legal entity, Plutus Investment Group LLP, was incorporated in England and Wales on 9 September 2021 under company number OC439090. Its registered office is Unit 1 Generator Hall, Electric Wharf, Coventry, England, CV1 4JL.

The London contact address and the registered office serve different purposes. Company registration details can be checked through the UK Companies House register.

Who are the members of the Plutus Investment Group team?

The management team presented on Plutus Investment Group's website includes Mohammed Jamal, Founder, CEO and Chairman, and Fahd Lahrach, Chief of Staff.

Mohammed Jamal's published biography covers his investment and financial-services background. Fahd Lahrach's biography describes a background in business law, legal and fiscal matters, and corporate development. It also lists a master's degree in Business Law and a certificate in M&A and Corporate Development Strategies from the Wharton School.

The About Us page provides further information about the management team and their professional backgrounds.

Which sectors does Plutus Investment Group invest in?

Plutus Investment Group identifies five investment sectors: life sciences, biotechnology, financial technology, technology and defence.

Its published portfolio illustrates these areas through businesses working on cancer diagnostics, antibiotic development, financial technology, enterprise software and secure communications. These categories describe the firm's investment focus; the activities of individual businesses are explained on the portfolio page and their own websites.

Which countries and regions does Plutus Investment Group focus on?

Plutus Investment Group's stated geographic focus is Europe and the United States. The firm seeks to support founders and businesses operating within these markets across its five investment sectors.

These regions describe the firm's broad investment focus. Founders seeking to establish whether a particular company fits the investment approach can contact the team with information about the business, its location and its development stage.

What types of companies and investment stages does Plutus target?

Plutus Investment Group describes its investment focus as early-stage companies in life sciences, biotechnology, financial technology, technology and defence.

The firm follows a selective approach, investing in a limited number of businesses each year. This allows it to dedicate time, capital and professional support to its portfolio. Founders can introduce their company through the official contact page, explaining their technology, market, development stage and funding needs.

Which companies are included in Plutus Investment Group's portfolio?

Plutus Investment Group's published portfolio lists businesses including Oxford Cancer Biomarkers, Amprologix, MPC Therapeutics and RemTech Group.

Oxford Cancer Biomarkers develops cancer diagnostic technologies. Amprologix works on new antibiotics to address antimicrobial resistance. MPC Therapeutics develops technologies intended to enhance T-cell therapies, while RemTech Group focuses on secure communications.

The portfolio page links to the companies' websites, allowing readers to explore their activities. Details of a specific investment, including its date, structure and current status, should be checked against the relevant transaction announcement or confirmed directly with Plutus.

How does Plutus support its portfolio companies beyond funding?

Plutus Investment Group describes its support as a combination of capital, strategic guidance, business development assistance and access to its network.

The firm aims to help founders develop their businesses, connect with relevant contacts and pursue commercial opportunities. Its approach emphasises long-term involvement and focused attention across a selective portfolio.

The scope of support for an individual company depends on its needs and the relationship agreed with Plutus.

How can founders, investors and existing partners contact Plutus Investment Group?

Founders, investors and strategic partners can contact Plutus Investment Group through the form on its official Contact page: https://www.plutus-investment.com/contact/.

Founders introducing a business can include a short company overview, sector, location, development stage and reason for contacting the team. Existing partners can also access the Partner Portal linked from the official website.

For enquiries about an existing investment or its documentation, providing the relevant company or transaction reference can help the team identify the appropriate contact.

Have another question?

Our team is here to help. Get in touch to discuss your company, an investment or a partnership.

Contact Us